Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;54(8):1409-1413.
doi: 10.1111/imj.16457. Epub 2024 Jul 17.

The burden of non-alcoholic fatty liver disease in Australia: an analysis of Global Burden of Disease study from 1990 to 2019

Elena S George  1 , Surbhi Sood  1 , Riaz Uddin  1 , Stuart K Roberts  2   3 , Sheikh M S Islam  1
Affiliations

The burden of non-alcoholic fatty liver disease in Australia: an analysis of Global Burden of Disease study from 1990 to 2019

Elena S George et al. Intern Med J. 2024 Aug.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease. Global Burden of Disease (GBD) data from 1990 to 2019 reported a rise in prevalence (9-13%) in Australia, which also ranked third highest for NAFLD prevalence compared to 14 similar countries. As a result of underdiagnosis, NAFLD burden is underestimated by GBD.

Keywords: GBD; burden; liver disease; non‐alcoholic fatty liver disease; prevalence.

PubMed Disclaimer

References

    1. The Social and Economic Cost of Primary Liver Cancer Hepatocellular Carcinoma (HCC) in Australia. Woolloongabba: QLD Liver Foundation; 2021.
    1. Adams LA, Roberts SK, Strasser SI, Mahady SE, Powell E, Estes C et al. Nonalcoholic fatty liver disease burden: Australia, 2019–2030. J Gastroenterol Hepatol 2020; 35: 1628–1635.
    1. Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1204–1222.
    1. Fan J‐G, Farrell GC. Epidemiology of non‐alcoholic fatty liver disease in China. J Hepatol 2009; 50: 204–210.
    1. Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 2018; 67: 123–133.

Publication types